Your session is about to expire
← Back to Search
Paclitaxel for Esophageal Cancer
Study Summary
This trial is studying how well paclitaxel works in treating patients with esophageal cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any current openings for patients in this clinical trial?
"Unfortunately, this study is not currently looking for candidates. Although the last update was on July 23rd, 2008, it was originally posted September 1st, 1997. There are 387 other trials that patients may be eligible for."
What are the associated risks of this treatment?
"As this is a Phase 2 trial, meaning there is only preliminary data supporting safety and none for efficacy, the treatment received a score of 2."
In how many different medical clinics is this research study being conducted today?
"In addition to other locations, this trial is being conducted out of Cancer Center of Southern Alabama in Mobile, Alabama, Loma Linda University Medical Center in Loma Linda, California, and Florida Cancer Specialists in Fort Myers, Florida."
Share this study with friends
Copy Link
Messenger